PRJNA737652
Synergistic tumor cytolysis by NK cells in combination with a pan-HDAC inhibitor, Panobinostat
This study was to investigate the epigenetic modifications exerted by the HDAC inhibitor Panobinostat on human melanoma cell line (A375)